Emergence of high-metastatic potentials and prediction of recurrence and metastasis
Open Access
- 23 December 2025
- journal article
- Published by Elsevier in Cell Reports
- Vol. 45 (1) , 116834
Abstract
No abstract availableKeywords
Funding Information
- Swiss Cancer Research Foundation (KFS-4965-02-2020)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (F02-12481F)
This publication has 114 references indexed in Scilit:
- A partial epithelial‐mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restrictionThe Journal of Pathology, 2024
- Gene Set Knowledge Discovery with EnrichrCurrent Protocols, 2021
- Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon CancerJAMA Network Open, 2020
- Missed diagnosis of cancer in primary care: Insights from malpractice claims dataJournal of Healthcare Risk Management, 2019
- Pan‐cancer survey of epithelial–mesenchymal transition markers across the Cancer Genome AtlasDevelopmental Dynamics, 2017
- An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipidsEuropean Journal of Lipid Science and Technology, 2015
- Loss of WNT‐TCF addiction and enhancement of HH‐GLI1 signalling define the metastatic transition of human colon carcinomasEMBO Molecular Medicine, 2010
- Human colon cancer epithelial cells harbour active HEDGEHOG‐GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansionEMBO Molecular Medicine, 2009
- Involvement of the Xenopus homeobox gene Xhox3 in pattern formation along the anterior-posterior axisCell, 1989
- The metastatic potential of experimental pulmonary metastasesJournal of Surgical Research, 1973